MSM/WCI Partnership To Investigate Mechanisms of Prostate Cancer: Planning Stage

MSM/WCI 合作研究前列腺癌机制:规划阶段

基本信息

  • 批准号:
    7515843
  • 负责人:
  • 金额:
    $ 7.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-29 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

Priority-Setting Stage Pilot Project #1 (Drs. Davidson and Hsieh) is fully conceived, planned and staffed. Consequently this project will be implemented immediately upon funding. Pilot project #2 will be selected during Year 1 by a Priority-setting process described as follows. We have selected an Internal Advisory Committee comprised of 6 cancer investigators: The two Lead Pis plus 2 additional members from each institution: Alec J. Davidson, PhD is an assistant professor in the Department of Anatomy and Neurobiology, and a member of the Neuroscience Institute and Circadian Rhythms and Sleep Disorders Program. Dr. Davidson has been pursuing research on the relationship between circadian clocks and cancer for 4 years, and is currently PI of an R21 grant from NCI to investigate this issue in a rat model of hepatocellular carcinoma. He is the MSM Lead-Pi of this grant application. Sandra Harris-Hooker, PhD is the Vice President and Associate Dean for Sponsored Research Administration at MSM, and the Director of the Minority Biomedical Research Support Program at Morehouse School of Medicine, a program dedicated to the development of future biomedical research scholars. With professional training in Cell Biology, and postgraduate emphasis in Cardiovascular Pathology, Dr. Harris- Hooker has worked in the area of vascular cell biology for over 20 years, studying enddthelial dysfunctions involved in the pathogenesis of atherosclerosis. While her primary research area is vascular biology, she is also interested in ways by which to enhance the integration of basic, clinical and population-based research in order to address disparities in health. Dr. Harris-Hooker has been on the MSM faculty since 1983. Daniel Blumenthal, MD, MPH, is Chairman of the Department of Community Health and Preventive Medicine and Principal Investigator of the Morehouse School of Medicine Prevention Research Center (PRC). The mission of the PRC is to advance scientific knowledge in the field of prevention of disease in African American and other minority communities and to disseminate new information and strategies of prevention. Specifically, Dr. Blumenthal is PI of the Cancer Prevention and Control Research network within the PRC, whose mission it is to accelerate the adoption of evidence-based cancer prevention and control in minority communities.
优先级设定阶段 试点项目#1(Davidson博士和Hsieh博士)已充分构思、规划和配备人员。因此该 该项目将在获得资金后立即实施。试点项目#2将在第一年由一个 确定优先事项的过程如下。 我们选择了一个由6名癌症研究人员组成的内部咨询委员会: 加上每个机构的2名额外成员: Alec J. Davidson博士是解剖学和神经生物学系的助理教授, 神经科学研究所和昼夜节律和睡眠障碍项目的成员。戴维森医生 4年来,他一直在研究生物钟与癌症之间的关系, 目前是NCI R21基金的PI,在大鼠肝细胞癌模型中研究该问题。他是 这份资助申请的男男性接触者领导人 Sandra Harris-Hooker博士是赞助研究的副总裁兼副院长 MSM的管理,以及Morehouse少数民族生物医学研究支持计划的主任 医学院,致力于未来生物医学研究学者的发展计划。与 Harris博士接受细胞生物学专业培训,研究生重点为心血管病理学- 胡克在血管细胞生物学领域工作了20多年,研究内皮功能障碍 参与动脉粥样硬化的发病机制。虽然她的主要研究领域是血管生物学,但她 还对如何加强基础、临床和人口研究的一体化感兴趣, 以解决健康方面的差距。Harris-Hooker博士自1983年以来一直担任MSM教师。 丹尼尔布卢门塔尔,医学博士,公共卫生硕士,是社区卫生和预防医学系主任 Morehouse医学院预防研究中心(PRC)的首席研究员。的 中华人民共和国的使命是促进非洲裔美国人疾病预防领域的科学知识 在这方面,我们将继续努力,以加强对少数民族和其他少数民族社区的保护,并传播新的信息和预防战略。具体地说, 博士布卢门塔尔是中国癌症预防和控制研究网络的主要负责人,其使命是 是在少数民族社区加速采用循证癌症预防和控制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LELAND W.K. CHUNG其他文献

LELAND W.K. CHUNG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LELAND W.K. CHUNG', 18)}}的其他基金

Beta 2-Microglobulin signaling and targeting in bone metastasis
骨转移中的 Beta 2-微球蛋白信号传导和靶向
  • 批准号:
    8100285
  • 财政年份:
    2009
  • 资助金额:
    $ 7.59万
  • 项目类别:
Beta 2-Microglobulin signaling and targeting in bone metastasis
骨转移中的 Beta 2-微球蛋白信号传导和靶向
  • 批准号:
    7655050
  • 财政年份:
    2009
  • 资助金额:
    $ 7.59万
  • 项目类别:
Beta 2-Microglobulin signaling and targeting in bone metastasis
骨转移中的 Beta 2-微球蛋白信号传导和靶向
  • 批准号:
    8301006
  • 财政年份:
    2009
  • 资助金额:
    $ 7.59万
  • 项目类别:
Beta 2-Microglobulin signaling and targeting in bone metastasis
骨转移中的 Beta 2-微球蛋白信号传导和靶向
  • 批准号:
    7941078
  • 财政年份:
    2009
  • 资助金额:
    $ 7.59万
  • 项目类别:
Beta 2-Microglobulin signaling and targeting in bone metastasis
骨转移中的 Beta 2-微球蛋白信号传导和靶向
  • 批准号:
    8510591
  • 财政年份:
    2009
  • 资助金额:
    $ 7.59万
  • 项目类别:
Imaging and Targeting Prostate Tumors with a novel near-infrared (NIR).....
使用新型近红外 (NIR) 成像和靶向前列腺肿瘤......
  • 批准号:
    7490246
  • 财政年份:
    2008
  • 资助金额:
    $ 7.59万
  • 项目类别:
Nanoparticle Imaging and Co-Targeting of Cancer and Bone Stroma
癌症和骨基质的纳米颗粒成像和联合靶向
  • 批准号:
    7737194
  • 财政年份:
    2008
  • 资助金额:
    $ 7.59万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7515848
  • 财政年份:
    2007
  • 资助金额:
    $ 7.59万
  • 项目类别:
MSM/WCI Partnership To Investigate Mechanisms of Prostate Cancer (2 Of 2)
MSM/WCI 合作研究前列腺癌机制(2 中的 2)
  • 批准号:
    7410220
  • 财政年份:
    2007
  • 资助金额:
    $ 7.59万
  • 项目类别:
MSM/WCI Partnership To Investigate Mechanisms of Prostate Cancer (2 Of 2)
MSM/WCI 合作研究前列腺癌机制(2 中的 2)
  • 批准号:
    7502659
  • 财政年份:
    2007
  • 资助金额:
    $ 7.59万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.59万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 7.59万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了